PharmaCyte Biotech (OTC: PMCB) Releases New Video Documentary of Its Pancreatic Cancer Treatment

OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has released a new video documentary of its pancreatic cancer therapy. The video, which was written and produced by Stock Market Media Group, uses storytelling to introduce the viewer to […]

Continue Reading

Aureus Inc./Yuengling’s Ice Cream (OTC: ARSN) Allies with Distribution Giants in Bid to Expand Product Presence to 20,000 Plus Potential Retailers, Adds Industry Veteran to Retailer Relationships Team

ATLANTA, GA / ACCESSWIRE / September 4, 2019 / Aureus, Inc. (OTC PINK:ARSN) (“Aureus” or the “Company”) (www.AureusNOW.com) an emerging leader in the food brand development industry which owns the Yuenglings Ice Cream brand (Yuenglings Ice Cream or Yuenglings) (www.yuenglingsicecream.com) including all the intellectual property and its distribution at select retail locations, unveils implementation of a […]

Continue Reading

West Coast Ventures (OTC: WCVC) has Paid off $1.4 Million of Convertible Debt

DENVER, Sept. 4, 2019 /PRNewswire/ — West Coast Venture Group, Corp. (WCVC) (“WCVC”) is pleased to expand on its plans to pay down all convertible debt owed to third parties by Q2 2020, or sooner. Since June 2018, the company has paid off – in cash – an aggregate amount of $1.4 million of convertible debt. The significant reduction in […]

Continue Reading

Tombstone Exploration Corporation (OTCQB: TMBXF) Announces Upgrade to OTCQB Markets; Permitting Continues on the Bonanza Gold Project

PHOENIX, Sept. 03, 2019 (GLOBE NEWSWIRE) — Tombstone Exploration Corporation (OTCQB:TMBXF), a fully reporting company, announced today in combination with the OTC Markets Group Inc. that TMBXF is approved for trading on the OTCQB Venture Markets as of August 27, 2019. While Tombstone has been a fully reporting company since its inception, the Company believes […]

Continue Reading

Medicine Man Technologies (OTC: MDCL)Unveils its Largest Deal Yet with Entry into a Term Sheet to Acquire a Group of Dispensaries Operating under the Starbuds Brand

The Company’s addition of a group of five dispensaries will increase the retail footprint and regional coverage of the Company in Colorado – As part of the agreement, one of the original industry pioneers, Brian Ruden, will join the Company’s Board of Directors, enhancing the depth of the senior management team, which is unrivaled in […]

Continue Reading

Cidara Therapeutics (NASDAQ: CDTX) and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin

SAN DIEGO, Calif. & CAMBRIDGE, England–(BUSINESS WIRE)– Cidara Therapeutics, Inc. (Nasdaq: CDTX) and Mundipharma announced today that they have entered into a strategic partnership to develop and commercialize rezafungin for the treatment and prevention of invasive fungal infections. Rezafungin is a novel, once-weekly echinocandin antifungal being developed for the first-line treatment of candidemia and invasive […]

Continue Reading

Columbia Care (OTCQX: CCHWF) and Moeller Pharma GmbH Enter into Exclusive Agreement to Develop Portfolio of Proprietary, Plant-Based Combination Cannabinoid Functional Health and Wellness Products

Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, announced that it has entered into an exclusive agreement with Moeller Pharma GmbH (“Moeller”), a GMP-certified German producer of high-quality herbal […]

Continue Reading

West Coast Ventures (OTC: WCVC)Pays off $1.4 Million of Convertible Debt

DENVER, Aug. 29, 2019 /PRNewswire/ — West Coast Venture Group, Corp. (WCVC) (“WCVC”) is pleased to expand on its plans to pay down all convertible debt owed to third parties by Q2 2020, or sooner. Since June 2018, the company has paid off – in cash – an aggregate amount of $1.4 million of convertible debt. The significant reduction in […]

Continue Reading

PharmaCyte Biotech (OTC: PMCB) Confirms Dr. Manuel Hidalgo Will Be Principal Investigator for Clinical Trial in Pancreatic Cancer

  (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that nationally and internationally renowned clinician and oncologist, Dr. Manuel Hidalgo, has confirmed that he will be Principal Investigator (PI) for PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic […]

Continue Reading

Green Growth Brands Completes Acquisition of Second The+Source Location

COLUMBUS, OH, Aug. 28, 2019 /PRNewswire/ – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or “the Company”) is pleased to announce the closing of its acquisition of Henderson Organic Remedies, LLC (The+Source Henderson), which was previously disclosed on December 14, 2018. The+Source Henderson is the second The+Source dispensary operated by GGB in greater Las Vegas. The productivity of The+Source […]

Continue Reading

Facebook

Would you like to stay up to date with the latest small cap news?  Enter your email.